Funding for this research was provided by:
Department of Health Research India (S.11011/08/2017-HR)
Received: 18 August 2020
Accepted: 6 December 2020
First Online: 6 January 2021
Ethics approval and consent to participate
: Since this was part of a larger HTA study, ethical approval was sought for the entire HTA study.
: Not applicable. (As we did not collect individual patient data for this study).
: The manufacturers of Nexplanon/Implanon-NXT are stakeholders in the HTA project undertaken by the technical partner of HTA-In. Technical inputs about the product were obtained from the manufacturers, they had no other influence (financial or otherwise) over the team that worked on the HTA/the decision makers. The team declares no conflict of interest.